FINWIRES · TerminalLIVE
FINWIRES

日本4月制造业增长,服务业放缓:PMI报告

-- 标普全球周四发布的数据显示,日本4月份私营部门持续扩张,制造业是自波斯湾战争以来日本经济复苏的早期迹象。 标普全球援引其月度调查报告称,日本4月份综合采购经理人指数(PMI)初值为52.4,低于3月份的53.0,但仍高于50荣枯分界线。该指数综合反映了日本制造业和服务业的产出情况。 标普全球补充道,日本4月份制造业PMI初值升至54.9,高于3月份的51.6;服务业PMI初值为51.2,低于上月的53.4。 标普全球表示:“尽管(日本)服务业企业在第二季度初的业务活动和销售额增长均有所放缓,但制造业在新增订单稳步增长的推动下,产量实现了12年来最大幅度的增长。” 日本私营企业在4月份再次增加了员工人数,但难以满足订单需求。 标普全球指出:“与产量和新增订单的趋势一致,日本企业在4月份小幅增加了员工人数。总体就业人数已连续两年半以上保持增长。” “然而,产能压力依然存在,未完成订单量连续第五个月增加。” 日本企业管理者还报告称,4月份运营成本有所上升。 标普全球表示:“受访企业普遍强调,员工、原材料、燃料和能源价格上涨。而能源价格上涨又与中东局势和日元疲软有关。” 中东局势也令日本企业经理人4月份的乐观情绪蒙上阴影。 标普全球表示:“4月份,企业对未来产出的信心连续第二个月减弱,整体乐观情绪降至2020年8月新冠疫情爆发以来的最低水平。尽管日本企业普遍对全球需求状况的改善抱有希望,但中东战争带来的不确定性和市场动荡抑制了部分企业的预期。” 这份日本PMI初值报告由标普全球根据4月9日至21日期间对400家制造商和400家服务提供商的调查数据编制而成。

Related Articles

Research

Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.

$HIG
Research

Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.

$BKR
Research

Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.

$WAB